Format

Send to

Choose Destination
Genes Dev. 2013 Oct 15;27(20):2221-6. doi: 10.1101/gad.227413.113. Epub 2013 Oct 8.

Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors.

Author information

1
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA;

Abstract

We previously identified 28 cofactors through which a RAS oncoprotein directs transcriptional silencing of Fas and other tumor suppressor genes (TSGs). Here we performed RNAi-based epistasis experiments and found that RAS-directed silencing occurs through a highly ordered pathway that is initiated by binding of ZFP354B, a sequence-specific DNA-binding protein, and culminates in recruitment of the DNA methyltransferase DNMT1. RNAi and pharmacological inhibition experiments reveal that silencing requires continuous function of RAS and its cofactors and can be rapidly reversed, which may have therapeutic implications for reactivation of silenced TSGs in RAS-positive cancers.

KEYWORDS:

DNMT1; RAS; RNA interference; ZFP354B; epigenetic silencing; epistasis analysis

PMID:
24105743
PMCID:
PMC3814642
DOI:
10.1101/gad.227413.113
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center